Send us Fan Mail

Meet Olie Bosley.

Olie is an IT and cybersecurity expert from Oxford, UK who has suffered from Crohn's disease symptoms for nearly 30 years.

We invited Olie to join us for this episode as he has an important story to share: what happens when the drug that has kept you well for so long - in his case Humira (adalimumab) - without notice causes you side effects that mean you need to stop taking it.

Olie speaks with candour to Nigel and me on the practical and psychological challenges this brings a patient who hitherto had well controlled inflammatory bowel disease. His story is a testament to resilience, advocating for oneself and the importance on inter-department communication when treating IBD patients.

🔍 What You’ll Learn

How a childhood injury may have shaped Olie’s health trajectory
The possible link between seronegative arthritis and Crohn’s disease
Why Olie delayed his first colonoscopy... and what changed his mind
The impact of NSAIDs on gut health and Crohn’s progression
Olie’s experience with methotrexate, azathioprine, Humira, infliximab, ustekinumab and Rinvoq
The overlooked reality of bile acid malabsorption after TI surgery
How UVB therapy helped resolve a Humira-related skin reaction
The importance of communication between rheumatology, dermatology and IBD teams

You can follow Olie Bosley on X (@Olski).

Follow Rachel at @bottomlineibd

Follow Nigel at @crohnoid

#18 When long-term stability on a Crohn's drug meets a curveball: an IBD patient's story

Wrestling the Octopus (IBD)